特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
793756

プレフィルドシリンジ:世界市場 (2023年)

Prefilled Syringes: Global Markets to 2023

出版日: | 発行: BCC Research | ページ情報: 英文 102 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
プレフィルドシリンジ:世界市場 (2023年)
出版日: 2019年02月21日
発行: BCC Research
ページ情報: 英文 102 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプレフィルドシリンジ (薬剤充填済み注射器) 市場は、2018年の47億米ドルから、2023年までに73億米ドルまで拡大すると見られています。市場は、2018年~2023年のCAGR (複合年間成長率) で、9.3%の成長が予測されています。

当レポートでは、世界のプレフィルドシリンジ (薬剤充填済み注射器) 市場について調査分析し、市場概要、市場区分と予測、セグメント別の市場予測、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場・技術背景

  • 技術概要
  • プレフィルドシリンジ市場の促進要因
  • プレフィルドシリンジ市場の抑制要因
  • 政府規制
  • 医療費償還

第4章 市場分析:素材別

  • イントロダクション
  • ガラス製プレフィルドシリンジ
  • プラスチック (ポリマー) 製プレフィルドシリンジ
  • 市場規模・予測

第5章 市場分析:種類別

  • イントロダクション
  • 従来型プレフィルドシリンジ
  • セーフティプレフィルドシリンジ
    • 自動格納シリンジ
    • 手動格納シリンジ
  • 市場規模・予測

第6章 市場分析:設計別

  • イントロダクション
  • シングルチャンバープレフィルドシリンジ
  • デュアルチャンバープレフィルドシリンジ
  • オーダーメイドプレフィルドシリンジ
  • 市場規模・予測

第7章 市場分析:治療別

  • ワクチン
  • モノクロナール抗体
  • その他
  • 市場規模・予測

第8章 市場分析:用途別

  • 糖尿病
  • アナフィラキシー
  • 関節リウマチ
  • その他
  • 市場シェア

第9章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第10章 プレフィルドシリンジ市場:エンドユーザー別

  • 病院
  • 在宅医療
  • 外来診療

第11章 特許レビュー/新規開発

第12章 市場機会/競合情勢の分析

第13章 企業プロファイル

  • 味の素アルテア
  • APTAR PHARMA
  • BAXTER INTERNATIONAL INC.
  • BECTON DICKINSON AND CO. GROUP PLC
  • BIOCORP
  • CATALENT PHARMA SOLUTIONS
  • CREDENCE MEDSYSTEMS INC.
  • ENABLE INJECTIONS, INC.
  • GERRESHEIMER AG
  • HASELMEIER
  • MEDTRONIC
  • NEMERA
  • ニプロ
  • SCHOTT AG
  • SHL MEDICAL
  • STEVANATO GROUP/OMPI
  • TERUMO MEDICAL CORP. (テルモ)
  • VETTER INTERNATIONAL
  • WEIGAO GROUP
  • WEST PHARMACEUTICAL SERVICES, INC.
  • YPSOMED HOLDING AG

第14章 付録

図表

List of Tables

  • Summary Table: Global Market for Prefilled Syringes, by Region, Through 2023
    • Table 1: List of Drugs Delivered Via Prefilled Syringes
    • Table 2: Components of Prefilled Syringes
    • Table 3: Global Market for Prefilled Syringes, by Material Type, Through 2023
    • Table 4: Global Market for Prefilled Syringes, by Type, Through 2023
    • Table 5: Prefilled Syringes for Lyophilized Drugs
    • Table 6: Global Market for Prefilled Syringes, by Design, Through 2023
    • Table 7: Drugs Administered Via Prefilled Syringes
    • Table 8: Global Market for Prefilled Syringes, by Therapy, Through 2023
    • Table 9: Global Market for Prefilled Syringes, by Application, Through 2023
    • Table 10: Global Market for Prefilled Syringes, by Region, Through 2023
    • Table 11: North American Market for Prefilled Syringes, by Country, Through 2023
    • Table 12: European Market for Prefilled Syringes, by Country/Region, Through 2023
    • Table 13: Asia-Pacific Market for Prefilled Syringes, by Country, Through 2023
    • Table 14: Rest of the World Market for Prefilled Syringes, by Country, Through 2023
    • Table 15: Global Market for Prefilled Syringes, by End User, Through 2023
    • Table 16: Patents and Patent Applications, 2016-2018
    • Table 17: Players in the Prefilled Syringes Industry
    • Table 18: New Products Launched by Key Players in the Prefilled Syringes Industry, 2016-2018*
    • Table 19: Mergers and Acquisitions, 2017 and 2018*
    • Table 20: Agreements, Collaborations and Partnerships Among Players in the Prefilled Syringes Industry, 2017 and 2018*
    • Table 21: Ajinomoto Althea, Inc.: Products and Services
    • Table 22: Aptar Pharma: Financials, 2016 and 2017
    • Table 23: Baxter International Inc.: Financials, 2016 and 2017
    • Table 24: Baxter International Inc.: Sales, by Division, 2016 and 2017
    • Table 25: Baxter International Inc.: Products and Services
    • Table 26: BD: Financials, 2016 and 2017
    • Table 27: BD: Products and Services
    • Table 28: Gerresheimer AG: Financials, 2016 and 2017
    • Table 29: Gerresheimer AG: Products and Services
    • Table 30: Nemera: Products and Services
    • Table 31: Nipro Corp.: Financials, 2016 and 2017
    • Table 32: Schott AG: Financials, 2016 and 2017
    • Table 33: Schott AG: Products and Services
    • Table 34: SHL Medical: Products and Services
    • Table 35: Terumo Medical Corp.: Financials, 2016 and 2017
    • Table 36: Terumo Medical Corp.: Products and Services
    • Table 37: Vetter: Products and Services
    • Table 38: Weigao Group: Financials, 2016 and 2017
    • Table 39: West Pharmaceuticals Services, Inc.: Financials, 2016 and 2017
    • Table 40: West Pharmaceuticals Services, Inc.: Net Sales, by Reportable Segments, 2016 and 2017
    • Table 41: West Pharmaceuticals Services, Inc.: Products and Services
    • Table 42: Ypsomed Holding AG: Financials, 2016 and 2017
    • Table 43: Ypsomed Holding AG: Products and Services
    • Table 44: Acronyms Used in This Report

List of Figures

  • Summary Figure: Global Market for Prefilled Syringes, by Region, 2017-2023
    • Figure 1: Global Market for Prefilled Syringes, by Material Type, 2017-2023
    • Figure 2: Global Market Share for Prefilled Syringes, by Material Type, 2017
    • Figure 3: Global Market for Glass and Polymer/Plastic Prefilled Syringes, by Region, 2017
    • Figure 4: Global Market for Glass and Polymer/Plastic Prefilled Syringes, by Region, 2023
    • Figure 5: Global Market for Prefilled Syringes, by Type, 2017-2023
    • Figure 6: Global Market for Conventional and Safety Prefilled Syringes, by Region, 2017
    • Figure 7: Global Market for Conventional and Safety Prefilled Syringes, by Region, 2023
    • Figure 8: Summary of Dual-Chamber Development Process
    • Figure 9: Global Market for Prefilled Syringes, by Design, 2017-2023
    • Figure 10: Global Market for Prefilled Syringes, by Therapy, 2017-2023
    • Figure 11: Global Market Share of Prefilled Syringes, by Application, 2017
    • Figure 12: Global Market Share of Prefilled Syringes, by Application, 2023
    • Figure 13: Global Market for Prefilled Syringes, by Region, 2017-2023
    • Figure 14: North American Market for Prefilled Syringes, by Material Type, 2017 and 2023
    • Figure 15: North American Market for Prefilled Syringes, by Type, 2017 and 2023
    • Figure 16: European Market for Prefilled Syringes, by Material Type, 2017 and 2023
    • Figure 17: European Market for Prefilled Syringes, by Type, 2017 and 2023
    • Figure 18: Asia-Pacific Market for Prefilled Syringes, by Material Type, 2017 and 2023
    • Figure 19: Asia-Pacific Market for Prefilled Syringes, by Type, 2017 and 2023
    • Figure 20: Rest of the World Market for Prefilled Syringes, by Material Type, 2017 and 2023
    • Figure 21: Rest of the World Market for Prefilled Syringes, by Type, 2017 and 2023
    • Figure 22: Global Market for Prefilled Syringes, by End User, 2017-2023
    • Figure 23: Global Market Shares of Key Players in the Prefilled Syringes Industry, 2017
    • Figure 24: BD: Revenue Share, by Segment, 2017
    • Figure 25: Gerresheimer AG: Revenue Share, by Product Segment, 2017
    • Figure 26: Nipro Corp.: Sales Share, by Business Segment, 2017
    • Figure 27: Terumo Medical Corp.: Revenue Share, by Country/Region, 2017
    • Figure 28: West Pharmaceuticals Services, Inc.: Net Sales Share, by Product Category, 2017
目次
Product Code: HLC223A

Report Highlights:

The global market for prefilled syringes should grow from $4.7 billion in 2018 to $7.3 billion by 2023 at a compound annual growth rate (CAGR) of 9.3% for the period of 2018-2023.

European prefilled syringes market should grow from $1.8 billion in 2018 to reach $2.7 billion by 2023 at a CAGR of 8.4% for the period of 2018-2023.

Asia-Pacific prefilled syringes market should grow from $863.6 million in 2018 to reach $1.5 billion by 2023 at a CAGR of 11.1% for the period of 2018-2023.

Report Scope:

This report analyzes the global market trends, future growth and regional markets of prefilled syringes with data from 2017, 2018, and projections of compound annual growth rates through 2023; the forecast period is 2018-2023. The market values for prefilled syringes are given for the years 2017, 2018 and 2023.

In this report, the market is segmented based on material, type, design and therapeutics. Based on materials, the report covers glass-based and polymer-based prefilled syringes. The market breakdown by type includes conventional and safety prefilled syringes. On basis of design, the market is segmented into single-chamber prefilled syringes, dual-chamber and customized prefilled syringes. In the therapeutics segment, the report reviews monoclonal antibodies and vaccines.

The report reviews the main prefilled syringes applications including rheumatoid arthritis, diabetes, anemia, cancer, multiple sclerosis, hormonal diseases and anaphylaxis. It then discusses some end users of prefilled syringes like hospitals, pharmacies and ambulatory surgical centers.

This report provides a comprehensive review of market dynamics such as market drivers, restraints and opportunities, and provides a list of available patents. A holistic study of the market has been carried out by incorporating various factors taken from country-specific demographic conditions and business cycles to market-specific microeconomic influences.

The research uncovers paradigm shifts in the market in terms of regional competitive advantages and the competitive landscape for key players in the prefilled syringes industry. An analysis of key vendors and their new products, developments and financials are provided to enable easy decision making. The list of companies profiled in this report are those involved in the production of prefilled syringes with injectable drugs; in the design, development and production of prefillable drug delivery systems including syringes, glass/polymer barrels, containers, vials, plungers and stoppers; and in filling and packaging services. The market size was obtained by considering the revenues of these companies.

This report also includes a summary of the main industry acquisitions and strategic alliances from 2016 through April 2018, including key alliance trends.

Estimated values are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 24 data tables and 21 additional tables
  • Industry analysis of the global markets for prefilled syringes within the healthcare sector
  • Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Regional dynamics of the prefilled syringes market covering North America, Europe, Asia-Pacific and other emerging economies
  • A look at key resins used to make these syringes, and new products and technologies related to these devices
  • Examination of the market dynamics, including growth inhibiting drivers, restraints, and opportunities
  • General assessment of key patents approved for prefilled syringes in the U.S., Europe and APAC region
  • Profiles of major manufacturers and suppliers of prefilled syringes, including Aptar Pharma, Baxter International Inc., Biocorp, Medtronic and West Pharmaceutical Services, Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Technology Overview
    • Properties of Prefilled Syringes
    • Filling Process in Prefilled Syringes
    • Sterilization of Prefilled Syringes
  • Factors Driving the Prefilled Syringes Market
    • Increasing Prevalence of Chronic Diseases
    • Increasing Adoption of Injectable Drugs
    • Development of Technologically Advanced Prefilled Syringes
    • Benefits Associated with Prefilled Syringes
    • Increasing Demand for Home-Based Healthcare Treatment
    • Improved Safety Standards
    • Increasing Demand for Self-Injection Devices
    • Huge Patient Population and Growing Aging Population
  • Factors Restraining the Prefilled Syringes Market
    • Determining Which PFS Material Works Best with the Drug Substance
    • High Costs Associated with Prefilled Syringes Hinder Widespread Adoption
    • Product Recalls Due to Breakages and Leachables
    • The Potential Risk of Interaction Between Prefilled Syringes and Drugs
    • Availability of Alternative Drug Delivery Methods
    • Competition
  • Government Regulations
    • Regulation of Prefilled Syringes
  • Reimbursement

Chapter 4: Market Breakdown by Material

  • Introduction
  • Glass Prefilled Syringes
  • Plastic (Polymer) Prefilled Syringes
  • Market Size and Forecast

Chapter 5: Market Breakdown by Type

  • Introduction
  • Conventional Prefilled Syringes
  • Safety Prefilled Syringes
    • Automatic Retractable Syringes
    • Manual Retractable Syringes
  • Market Size and Forecast

Chapter 6: Market Breakdown by Design

  • Introduction
  • Single-Chamber Prefilled Syringes
  • Dual-Chamber Prefilled Syringes
  • Customized Prefilled Syringes
  • Market Size and Forecast

Chapter 7: Market Breakdown by Therapy

  • Vaccines
  • Monoclonal Antibodies
  • Others
  • Market Size and Forecast

Chapter 8: Market Breakdown by Application

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Others
  • Market Share

Chapter 9: Market Breakdown by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 10: Prefilled Syringes Market by End User

  • Hospitals
  • Home Care
  • Ambulatory Care

Chapter 11: Patent Review/New Developments

Chapter 12: Analysis of Market Opportunities/Competitive Landscape

  • New Products
  • Mergers and Acquisitions
  • Agreements, Partnerships and Collaborations

Chapter 13: Company Profiles

  • AJINOMOTO ALTHEA, INC.
  • APTAR PHARMA
  • BAXTER INTERNATIONAL INC.
  • BECTON DICKINSON AND CO. GROUP PLC
  • BIOCORP
  • CATALENT PHARMA SOLUTIONS
  • CREDENCE MEDSYSTEMS INC.
  • ENABLE INJECTIONS, INC.
  • GERRESHEIMER AG
  • HASELMEIER
  • MEDTRONIC
  • NEMERA
  • NIPRO CORP.
  • SCHOTT AG
  • SHL MEDICAL
  • STEVANATO GROUP/OMPI
  • TERUMO MEDICAL CORP.
  • VETTER INTERNATIONAL
  • WEIGAO GROUP
  • WEST PHARMACEUTICAL SERVICES, INC.
  • YPSOMED HOLDING AG

Chapter 14: Appendix

  • Acronyms
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.